Abstract
Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating Type 1 regulatory T cells
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.11386/jst.57.supplement_s350_2
Copy DOIJournal: Japanese Journal of Transplantation | Publication Date: Jan 1, 2022 |
License type: free |
Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating Type 1 regulatory T cells
Join us for a 30 min session where you can share your feedback and ask us any queries you have